Home » Covalon Receives European Patent for Drug Delivery
Covalon Receives European Patent for Drug Delivery
Covalon Technologies announced that it has received European Patent protection for a drug delivery technology using liposomes within collagen-based hydrogel. The technology can be used as a drug delivery platform involving the retention of a drug within liposomes which are microscopic spheres of lipid designed to act as time-release drug depots.
CCNMatthews (http://www2.ccnmatthews.com/scripts/ccn-release.pl?/2005/05/02/0502116n.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May